Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons

Journal of Infectious Diseases

Volumn 179, Issue 3, 1999, Pages 538-547

  Bernard, Nicole F ^a   Yannakis, Christina M ^a   Jimmy S, Lee ^a,b   Tsoukas, Christos M ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPOSURE; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFECTION RISK; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEMORY CELL; PRIORITY JOURNAL; SCREENING; SEROCONVERSION;

ADULT; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HIV; HIV SERONEGATIVITY; HUMANS; IMMUNITY, NATURAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; NEEDLESTICK INJURIES; RECEPTORS, CCR5; SEXUAL BEHAVIOR; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033402209     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314621     Document Type: Article

References (50)

1. 1. Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type I-seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-9.
2. 2. Paxton WA, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high risk sexual exposure. Nat Med 1996;2:412-4.
3. 3. Ranki A, Mattinen S, Yarchoan R, et al. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. AIDS 1989;3:63-9.
4. 4. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 1994;93:1293-7.
5. 5. Mazzoli S, Trabattoni D, Caputo SL, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997;3:1250-7.
6. 6. Burger H, Weiser B, Robinson WS, et al. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Am J Med 1986; 81:5-10.
7. 7. MacGregor RR, Dubin G, Frank I, Hodinka RL, Friedman HM. Failure of culture and polymerase chain reaction to detect human immunodeficiency virus (HIV) in seronegative steady sexual partners of HIV-infected individuals. Clin Infect Dis 1995;21:122-7.
8. 8. Beretta AL, Furci S, Burastero A, et al. HIV-1 specific immunity in persistently seronegative individuals at high risk for HIV infection. Immunol Lett 1996;51:39-43.
9. 9. Rowland-Jones SL, Nixon DF, Aldhous MC. et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993;341: 860-1.
10. 10. Clerici M, Sison AV, Berzofsky JA, et al. Cellular immune factors associated with mother-to-infant transmission. AIDS 1993;7:1427-33.
11. 11. De Maria A, Cirillo C, Moretta L. Occurrence of human immunodeficiency virus type I (HIV-1) specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 1994;170: 1296-9.
12. 12. Cheynier R, Langlade-Demoyen P, Marescot MR, et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 1992;22: 2211-7.
13. 13. Clerici M, Levin JM, Kessler HA, et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994;271:42-6.
14. 14. Pinto L, Sullivan J, Berzofsky JA, et al. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 1995;96:867-76.
15. 15. Rowland-Jones S, Sutton J, Ariyoshi K, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59-64.
16. 16. Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996;348:1347-51.
17. 17. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
18. 18. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
19. 19. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
20. 20. Huang Y, Paxton W, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3.
21. 21. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997;3:338-40.
22. 22. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion protein for macrophage-tropic HIV-1, Science 1996;272:1955-8.
23. 23. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85: 1135-48.
24. 24. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
25. 25. Doranz BJ, Ruckner J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
26. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
27. 27. Feng Y, Broder CC, Kennedy PE, Berger EA, HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
28. 28. Rana S, Besson G, Cook DG, et al. Role of CCR5 in infection of primary macrophages and lymphocytes by M-tropic strains of HIV: resistance to patient-derived and prototype isolates resulting from the Δccr5 mutation. J Virol 1997;71:3219-27.
29. 29. Biti R, French R, Young J, Bennetts B, Stewart G. HIV-1 infection in an individual homozygous for the CCR5 deletion mutant. Nat Med 1997; 3:252-3.
30. + T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J Exp Med 1997;186:455-60.
31. 31. Levy JA. HIV pathogenesis and long term survival. AIDS 1993;7:1401-10.
32. 32. Blumberg RS, Paradis T, Byington R, Henle W, Hirsch MS, Schooley RT. Effects of human immunodeficiency virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production. J Infect Dis 1987;155:877-90.
33. 33. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-81.
34. + T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type I. J Virol 1996;70:8758-64.
35. 35. Hoffman TL, MacGregor RR, Burger H, Mick R, Doms RW, Collman RG. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type I infection status. J Infect Dis 1997;176:1093-6.
36. 36. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
37. 37. Cherwinski HM, Shumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clones. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166:1229-44.
38. 38. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
39. 39. Mosmann TR, Moore KW. The role of IL-10 in cross regulation of Th1 and Th2 responses. Immunol Today 1991;12:A49-53.
40. 40. Bretscher PA, Wei G, Menon JM, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992;257:539-42.
41. 41. Yang X, Hayglass KT, Brunham RC. Genetically determined differences in IL-10 and IFN responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996;156:4338-44.
42. 42. Bloom BR, Modlin RL, Salgame P. Stigma variations: observations on suppressor T cells and leprosy. Annu Rev Immunol 1992;10:453-88.
43. 43. Bloom BR, Salgame P, Diamond B. Revisiting and revising suppressor T cells. Immunol Today 1992;13:131-6.
44. 44. Abel L, Demenais F, Prata A, Souza AF, Dessain A. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991;48:959-70.
45. 45. Couissinier-Paris P, Dessein AJ. Schistosoma-specific T helper cell clones from subjects resistent to infection by Schistosoma mansoni are Th0/2. Eur J Immunol 1995;25:2295-302.
46. 46. Bronowicki JP, Vetter D, Uhl G, et al. Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-sero-negative spouses of HCV-infected patients. J Infect Dis 1997;176:518-22.
47. 47. Clerici M, Clark EA, Polacino P, et al. T-cell proliferation to sub-infectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994;8:1391-5.
48. 48. Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM. A strategy for prophylactic vaccination against HIV. Science 1993;260:1270-2.
49. 49. Yang OO, Kalams SA, Rosenzweig M, et al. Efficient lysis of human immunodeficiency virus type I-infected cells by cytolytic T lymphocytes. J Virol 1996;70:5799-806.
50. + cells: evidence for HLA class I restricted triggering of cytolytic and noncytolytic mechanisms. J Virol 1997;71:3120-8.